Swedish Orphan Biovitrum AB (OSTO:SOBI)
kr 276.4 3 (1.1%) Market Cap: 93.94 Bil Enterprise Value: 112.63 Bil PE Ratio: 43.61 PB Ratio: 2.63 GF Score: 87/100

Q1 2024 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Apr 25, 2024 / 02:00PM GMT
Release Date Price: kr280.8 (+5.41%)
Operator

Ladies and gentlemen, welcome to the Q1 Results 2024 Conference Call and Live Webcast. I am Alice the Chorus Call operator. (Operator Instructions). The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and welcome, everybody. And with this having said, let's go straight to the first slide. It's really a pleasure to welcome you today to our Q1 report. And today, I'm -- a forward-looking statement as the usual. Today, I'm joined by Henrik Stenqvist, our Chief Financial Officer; and Lydia Abad-Franch, our Head of R&D and CMO. And in the Q&A session, we will have also Armin Reininger, our Senior Scientific Adviser. Please go to the next slide.

So, I mean, you have seen the results this morning. And the result was excellent from our perspective is plus 30% versus previous year. I think this way even more up

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot